Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 9Breast Neoplasms 6Neoplasms 4Colorectal Neoplasms 3Multiple Myeloma 2Insulin Resistance 2Cardiotoxicity 2Weight Loss 1Warts 1Skin Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Fatigue 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Cachexia 1Brenner Tumor 1Bone Metastases 1Body Weight 1

Interventions

Megestrol Acetate 2Resistance Training 1Mirtazapine 1Metformin 1Exercise 1Doxorubicin 1Dietary Supplements 1Diet Therapy 1Cyclophosphamide 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Body Weight × Exercise × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡